Target intelligence / Profile preview

Serpin family B member 1 (SERPINB1)

Target
SERPINB1
Molecular classification
Serine protease inhibitor, Serpin (serine protease inhibitor) family, Clade B serpin (ovalbumin-related), Intracellular proteinase inhibitor
01

Overview

Serpin family B member 1 (SERPINB1) is an intracellular serine protease inhibitor of the clade B serpin family, best known as the leukocyte elastase inhibitor or monocyte/neutrophil elastase inhibitor. It is highly expressed in neutrophils and other immune cells, where it inhibits neutrophil serine proteases such as elastase, cathepsin G, and proteinase 3, protecting cells and tissues from the destructive effects of these enzymes released during inflammation or stress. SERPINB1 plays an important role in regulating the survival and function of mature neutrophils and ensures the maintenance of the neutrophil reserve during immune responses by opposing protease-driven cell death. Its functions extend beyond innate immunity to involvement in wound healing, cell migration, and possibly the modulation of tumor cell aggressiveness in certain malignancies. There are no current drugs directly targeting SERPINB1, but its levels or functional activity may serve as useful biomarkers in inflammatory diseases and cancer.

Other names
Leukocyte elastase inhibitorLEIMonocyte/neutrophil elastase inhibitorELANH2MNEIPI-2PI2EIHEL-S-27HEL57epididymis luminal protein 57epididymis secretory protein Li 27peptidase inhibitor 2protease inhibitor 2 (anti-elastase)
02

Mechanism of action

Inhibition of serine protease activity (e.g., neutrophil elastase, cathepsin G, proteinase 3) through a suicide-substrate (stressed-to-relaxed) conformational mechanism; limits excessive proteolytic damage and regulates downstream inflammatory signaling and cell survival

03

Biological functions

Regulation of innate immune responseInhibition of neutrophil serine proteases (elastase, cathepsin G, proteinase 3)Protection of cells from cytoplasmic proteases during stress or infectionRegulation of inflammation and tissue homeostasisModulation of NETosis (neutrophil extracellular trap formation)Cellular apoptosis regulation (anti- and pro-apoptotic roles depending on context)Cell migration and tissue repair
04

Disease associations

Chronic inflammation (e.g., COPD, pulmonary emphysema)Immune-mediated tissue injuryCancer (variously described as both a suppressor or promoter of migration, context-dependent)Autoimmune/infectious diseases (through modulation of neutrophil function)
05

Safety considerations

Therapeutic modulation may have safety concerns including vulnerability to tissue damage from increased neutrophil protease activityImpaired inflammatory resolutionPotential interference with innate immunityMost data relate to knockout mice or disease associations
06

Interacting drugs

None established as approved or widely recognized clinical therapeutics; specific drugs that directly target SERPINB1 are not reported in current clinical use or in the major drug databases
07

Biomarkers

Neutrophil dysfunction and survival (especially in neutropenia)Disease activity in chronic airway diseases (e.g., COPD, emphysema)Some cancers (tumor aggressiveness or migration potential, but evidence is cell type–specific and emerging)

Beyond the preview

Go deeper on Serpin family B member 1 (SERPINB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family B member 1 (SERPINB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call